|
14/05/2020 |
CIGB-258 at COVID-19 |
CIGB |
Registered outdated |
|
29/05/2020 |
Heberon Alfa R in COVID-19 |
MINSAP_AM |
Registered outdated |
|
03/07/2020 |
Stem cells in patients with lung lesions (COVID-19) |
IHI |
Registered outdated |
|
03/07/2020 |
PLASMA TREATMENT TO ASYMPTOMATIC PATIENT WITH COVID-19 INFECTION |
IHI |
Registered outdated |
|
22/06/2020 |
VIDA study |
CIGB |
Registered outdated |
|
14/07/2020 |
Safety and immunogenicity of the CIGB 2020. |
CIGB |
Registered outdated |
|
11/08/2020 |
CIMAvax-EGF in Bladder cancer |
CIM |
Registered outdated |
|
13/08/2020 |
SOBERANA 01 |
FINLAY |
Registered outdated |
|
01/10/2020 |
Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III. |
CIM |
Registered outdated |
|
27/10/2020 |
Prevalence of positive evolutive PCR in patients with COVID 19 treated with rectal ozone therapy: observational study prospective cohort. |
CPN |
Registered outdated |
|
06/11/2020 |
Observational study of the benefits of rectal ozonotherapy and BIOPLA as complemetary theraphy in convalescent patients with SARS-COV 2 |
CPN |
Registered outdated |
|
19/11/2020 |
NeuroEPO-Ataxia-Adults-Phase III |
CIM |
Registered outdated |
|
24/11/2020 |
Curmeric-Prevention-COVID-19-Health Workers-University Hospital General Calixto Garcia |
CEADEN |
Registered outdated |
|
26/11/2020 |
ABDALA Clinical Study |
CIGB |
Registered outdated |
|
26/11/2020 |
MAMBISA Study |
CIGB |
Registered outdated |
|
17/12/2020 |
SOBERANA 02A |
FINLAY |
Registered outdated |
|
22/01/2021 |
Curmeric- Safety-Community-Quarantine-COVID-19 |
CEADEN |
Registered outdated |
|
22/01/2021 |
Curmeric- Safety-Efficacy- Community-Quarantine-COVID-19 |
CEADEN |
Registered outdated |
|
22/01/2021 |
Curmeric- Nasal-Safety-Efficacy- Community-Quarantine -COVID-19 |
CEADEN |
Registered outdated |
|
11/03/2021 |
Phyisician Led CIMAvax-EGF lung biomarkers |
CIM |
Registered outdated |
